奥曲肽治疗177例肝硬化并发上消化道出血患者临床疗效研究

doi:10.3969/j.issn.1672-5069.2018.01.029

Abstract

Wang Ming, Ni Zhi. Clinical efficacy of octreotide in the treatment of 177 patients with liver cirrhosis complicated by upper gastrointestinal bleeding[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 114-115.

References

[1] 邱教,项时昊,李访贤,等.奥美拉唑联合奥曲肽治疗肝硬化上消化道出血82例.中国药业,2013,22（5）:106-107.
[2] 宋奇峰,周建波,桑建忠,等.奥曲肽联合奥美拉唑治疗肝硬化上消化道出血的疗效观察.中国生化药物杂志,2016,36（8）:127-129.
[3] 中华医学会肝病学分会、消化病学分会、内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治指南. 实用肝脏病杂志,2016,19（5）：Ⅰ-ⅩⅤⅠ.
[4] 杨辉,周筱燕,周岩芬,等.奥曲肽联合隔下逐瘀汤治疗肝硬化上消化道出血患者临床疗效和血流动力学的变化.实用肝脏病杂志,2016,19（4）:459-462.
[5] 张击波. 奥曲肽联合普萘洛尔对肝硬化上消化道出血患者血流动力学指标的影响.中国基层医药,2014,34（23）:3630-3631,3632.
[6] 张超.凝血酶联合奥曲肽治疗肝硬化并发上消化道出血的疗效观察. 现代消化及介入诊疗,2015,20（5）:526-527.
[7] 丁敏,亢锴. 奥曲肽治疗肝硬化并发上消化道出血的疗效和药物经济学评价. 现代消化及介入诊疗,2016,21（1）:14-16.
[8] 王学兵.探讨奥曲肽治疗乙肝肝硬化并发上消化道出血的临床疗效. 中国医学创新,2011,25（8）:25-26.
[9] 翟攀. 奥曲肽联合奥美拉唑治疗肝硬化上消化道出血临床观察. 实用临床医药杂志,2013,17（5）:80-82.
[10] Waidmann O,Brunner F,Herrmann E,et al. Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis. J Hepatol,2013,58（5）:956-961.
[11] 罗丹.奥曲肽与奥美拉唑联合方案治疗肝硬化并发上消化道出血的临床疗效评价. 中国医药指南,2016,14（7）:122-122,123.
[12] 张驰松.奥曲肽治疗乙肝肝硬化并发上消化道出血的临床疗效分析. 北方药学,2016,13（9）:41-41.

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[3]	Zhu Yage, Liu Jinfeng.. Therapeutic efficacy of adenosine methionine and glycyrrhizin combination in treatment of patients with alcoholic cirrhosis and its effect on serum BGP levels [J]. Journal of Practical Hepatology, 2019, 22(6): 872-875.
[4]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[5]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[6]	Liu Li, Yang Lie, Chen Haiyang, et al.. Changes of hemodynamics after splenectomy combined with pericardial devascularization in patients with cirrhotic portal hypertention complicated by splenic artery steal syndrome [J]. Journal of Practical Hepatology, 2019, 22(6): 884-887.
[7]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[8]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[9]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[10]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[11]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[12]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[13]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.
[14]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[15]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.

Clinical efficacy of octreotide in the treatment of 177 patients with liver cirrhosis complicated by upper gastrointestinal bleeding

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments